Results 121 to 130 of about 2,823 (147)

[Contribution to anticholesteremic agents?].

Ugeskrift for laeger, 1998
P, Astrup, F, Gyntelberg
openaire   +1 more source

[Clinical evaluation of anticholesteremic agents].

Naika. Internal medicine, 1968
T, Kimura, H, Kudo
openaire   +1 more source

[Effects and side-effects of anticholesteremic agents].

Nihon rinsho. Japanese journal of clinical medicine, 1969
Y, Yoshitoshi, C, Naito
openaire   +1 more source

[Arteriosclerosis with special reference to anticholesteremic agents].

Naika. Internal medicine, 1970
M, Murakami, H, Sekimoto, I, Nakada, T, Takegoshi, N, Iwaki   +4 more
openaire   +1 more source

[CLINICAL CONTRIBUTION TO THE STUDY OF A NEW SYNTHETIC ANTICHOLESTEREMIC AGENT: BETA-BENZALBUTYRRAMIDE].

Minerva medica, 1996
A, GIULIANI, V, SAMMARTINO
openaire   +1 more source

[Prevention of ischemic heart disease by changing diet and anticholesteremic agents. Risk hysteria or evidence-based work of physicians?].

Ugeskrift for laeger, 2000
S, Stender, A V, Astrup
openaire   +1 more source

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

Cancer Chemotherapeutic Agents

Ca-A Cancer Journal for Clinicians, 1981
exaly   +2 more sources

Lomitapide and Mipomersen

Circulation, 2014
Daniel J Rader, Oliviero Olivieri
exaly  

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly